CSBR Dividend: Champions Oncology Inc Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

CSBR Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	04/30/2025	04/30/2024	04/30/2023	04/30/2022	04/30/2021
Revenue	56	56	50	53	49	41
Revenue Growth (YoY)	10%	12%	-6%	8%	20%	28%
Cost of Revenue	29	28	29	29	23	21
Gross Profit	27	28	20	24	25	19
Selling, General & Admin	17	16	18	17	15	12
Research & Development	7	6	9	11	9	7
Operating Expenses	24	23	27	28	24	19
Other Non Operating Income (Expenses)	0	0	--	0	0	0
Pretax Income	2	4	-7	-5	0	0
Income Tax Expense	0	0	0	0	0	0
Net Income	2	4	-7	-5	0	0
Net Income Growth	-167%	-157%	40%	--	--	-100%
Shares Outstanding (Diluted)	13.78	14.26	13.54	13.54	14.16	14.57
Shares Change (YoY)	-2%	5%	0%	-4%	-3%	23%
EPS (Diluted)	0.2	0.32	-0.53	-0.39	0.04	0.02
EPS Growth	-179%	-161%	38%	-1,075%	100%	-112%
Free Cash Flow	7	6	-6	1	4	-4
Free Cash Flow Per Share	0.5	0.42	-0.44	0.07	0.28	-0.27
Gross Margin	48.21%	50%	40%	45.28%	51.02%	46.34%
Operating Margin	5.35%	7.14%	-12%	-7.54%	0%	0%
Profit Margin	3.57%	7.14%	-14%	-9.43%	0%	0%
Free Cash Flow Margin	12.5%	10.71%	-12%	1.88%	8.16%	-9.75%
EBITDA	4	5	-5	-2	1	1
EBITDA Margin	7.14%	8.92%	-10%	-3.77%	2.04%	2.43%
D&A For EBITDA	1	1	1	2	1	1
EBIT	3	4	-6	-4	0	0
EBIT Margin	5.35%	7.14%	-12%	-7.54%	0%	0%
Effective Tax Rate	0%	0%	0%	0%	0%	0%